ENOS expression Endothelial nitric oxide synthase

O2. Endothelial nitric oxide synthase (eNOS) also produces O2 but production of O2 vs. NO is determined by the amount of fully reduced tetrahydrobiopterin (BH4) available, with BH4 suppressing 02 in favor of NO. On a cautionary note, 02 production by many systems may represent a non-physiological activity expressed only when native activity is compromised in some way. 

Markers of inflammation, especially CRP (measured with a highly sensitive technique, referred to as hs-CRP), have become the center of attention in recent years (22). This increased interest stems from several important observations made by Ridker and co-workers. Serum CRP has been shown to be an independent cardiovascular disease risk factor (23,24). High levels predict CAD death in healthy middle-aged men (25) and in patients with unstable CAD (26). In acute coronary syndromes, serum CRP concentrations correlate with the severity of endothelial dysfunction (27). In the CARE trial, subjects with elevated markers of inflammation (CRP and serum amyloid A > 90th percentile) were at high cardiovascular risk and responded best to pravastatin treatment in terms of cardiovascular risk reduction (28). The statin also reduced serum CRP concentrations (29). CRP co-incubated with LDL is readily taken up by macrophages, in contrast to native LDL, suggesting that CRP could promote foam cell formation (30). A link with endothelial dysfunction may be related to the fact that CRP decreases endothelial nitric oxide synthase (eNOS) expression and bioactivity in human aortic endothelial cells (31). 

An important link may exist between nitric oxide (NO), a crucial mediator of vascular tone and platelet function, and the activation of COX. It has been reported that there is a NO-mediated increased COX activity in endothelial cells. This has now been attributed to the formation of peroxynitrite (produced from an interaction between NO and superoxide anions) that directly activates COX. However, this interaction is complex and may depend on the quantity and source of NO as well as on the specific COX isoforms (Davidge, 2001). This interplay between prostanoid and NO production appears to be particularly important for the function of the ocular vascular endothelium, where the effect of NO in the eye is largely mediated via PGI, and specific prostanoids have been shown to regulate endothelial nitric oxide synthase (eNOS) expression and activity in the ocular blood vessels (Hardy et al, 2000). 

Chlorine inhalational damage is not restricted to particular cell types, such as epitiielial cells. Injury caused by inhaled chlorine can be complex and involves multiple pathways (Figure 36.1). The loss of vascular tone following chlorine exposure has been linked to dysfunctional nitric oxide (NO)-dependent mechanisms and resulting vasodilation (Honavar et al., 2011). To address the role of NO, Honavar et al. (2014) found that when rats were exposed to a total chlorine concentration of 12,000 ppm X min, isolated pulmonary artery studies showed disruption of vascular tone due to disrupted NO signaling. The balance between endothelial nitric oxide synthase (eNOS)- and inducible nitric oxide s)mthase (iNOS)-derived NO was disrupted by chlorine. The expression and activation of eNOS and iNOS... 

Figure 6. Comparative gene expression ratios in ARF kidneys of MSC- and vehicle-treated animals. Data were generated by referencing each gene to p-actin as internal control. A MSC treatment cansed significant (P < 0.05) suppression (> 10 fold) of proinflammatory IL-ip, TNF a, and IFN-y (above bars actnal valnes). Anti-inflammatory lL-10 was robustly expressed in MSC-and not in vehicle treated animals. Filled bars on all panels depict gene expression ratio of 1, i.e., a value obtained when gene expression ratios between MSC- and vehicle-treated animals are "equal. B MSC treatment cansed increased gene expression of bFGF and TGF-a, whereas that of HGF was suppressed. C antiapoptotic Bcl-2 expression was robnstly indnced, whereas that of inducible nitric oxide synthase (iNOS) was snppressed in MSC- vs. vehicle-treated animals. eNOS, endothelial NOS.

Nitric Oxide Synthase Expression and Activity Nitric Oxide Synthase Uncoupling. Inhibitory effects of quercetin on the activity or expression of endothelial NO synthases (eNOS and iNOS) has been reported but only at high concentrations (< 50 pM) [Camuesco et al., 2004 Chiesi and Schwaller 1995]. Therefore, direct changes in endothelial NO expression or activity, even when relevant to other polyphenolics, do not appear to be physiologically relevant for quercetin. However, quercetin may restore NOS expression or activity when unpaired by pathological stimuli. In fact, eNOS expression, which is up-regulated in SHR, can be corrected by chronic quercetin administration... 

Nitric oxide ( NO) also contributes to the alveolar epithelium s oxidant burden, primarily as a result of the formation of reactive oxygen or nitrogen species. NO, one of the smallest and most distinctive biological mediators, is generated by nitric oxide synthase (NOS) which has three isoforms neuronal (nNOS, isoform I), inducible (iNOS, isoform II) and endothelial (eNOS, isoform III). nNOS and eNOS are constitutively expressed in cells and generate NO in small quantities for brief periods of time in response to increased intracellular CA2+ concentrations. It is currently unclear whether the level of expression or the enzymatic activity or either eNOS or nNOS is modulated by pathogens or inflammatory stimuli. 

NO is an important neuromodulator in the retina, and is implicated in many physiological processes (Goldstein et al., 1996). NO is synthesized from arginine via the action of nitric oxide synthase (NOS). Three distinct isoforms of NOS have been identified. Neuronal NOS (nNOS) and endothelial NOS (eNOS) are Ca -dependent. nNOS is constitutively expressed by certain types of amacrine cells in the retina. These cells often have long projections in the irmerplexiform layer (Sharma et al., 1997 Sharma et al., 2001). eNOS is expressed by the endothelial cells of blood vessels (Cheon et al., 2003). iNOS is Ca -independent and expressed in Muller and RPE cells in response to certain stimuli (Lopez-Costa et al., 1997). Activation of the NMDA receptor leads to an increase in intracellular calcium levels, which can induce expression of, and activate NOS isoforms, either directly (nNOS) or via the activation of calcium-dependent protein kinase C (PKC) (Lipton, 1999) (O Figure 3-6). 

FIGURE I All isoforms of nitric oxide synthase (NOS) can be expressed in the central nervous system (CNS). Neurons express primarily neuronal NOS (nNOS) but a subset of neurons have been identified which express endothelial NOS (eNOS). Endothelial cells also express eNOS. Under certain pathological conditions astrocytes, microglia, and smooth muscle cells are induced to express immunologic NOS (iNOS). All of these isoforms are sensitive to inhibition by NOS inhibitors. Therefore, systemic administration of most NOS inhibitors can have multiple effects in the CNS. 

---